Ironwood Pharmaceuticlas (Cambridge, MA) a clinical-stage company focused on therapeutics for constipation and irritable bowel syndrome, closed a $50M Series G financing. Participants include Morgan Stanley Investment Management, Ridgeback Capital, Sigma Capital Management, Jennison Associates, Maverick Capital and Paperboy Ventures.